Besides, downregulation of peroxisome proliferator-activated receptor-gamma co-activator (PGC)-1α was also reported to contribute to MPC1 silencing at transcriptional level in breast cancer [24], renal cell carcinoma [16] and cholangiocarcinoma [17]. This evidence concerns the gene PPARGC1A and breast cancer.